Candela's Smoothbeam Receives FDA Clearance for Acne.Business Editors & Health/Medical Writers WAYLAND, Mass.--(BUSINESS WIRE)--Oct. 7, 2002 To Brief Wall Street via Conference Call on October 8th at 11:30 AM (ET) Candela candela (kăndĕ`lə), in weights and measures: see candle. A unit of measurement of the intensity of light. Part of the SI system of measurement, one candela (cd) is the monochromatic radiation of 540THz with a radiant intensity Corporation (NASDQ: CLZR) announced today that its Smoothbeam(TM) is the first laser to receive marketing clearance from the U.S. Food and Drug Administration for the treatment of acne on the back and the first device to demonstrate a direct effect on the sebaceous glands Sebaceous glands —Tiny structures in the skin that produce oil (sebum). If they become plugged, sebum collects inside and forms a nurturing place for germs to grow. . Gerard E. Puorro, Candela's President and Chief Executive Officer announced: "This FDA FDA abbr. Food and Drug Administration FDA, n.pr See Food and Drug Administration. FDA, n.pr the abbreviation for the Food and Drug Administration. clearance represents a significant step forward for our company. Smoothbeam can help improve the lives of tens of millions of teen and adult acne patients who are dissatisfied with topical and systemic treatments, and wary of their risks and side effects Side effects Effects of a proposed project on other parts of the firm. ." In conjunction with this announcement, the Company invites you to participate in a conference call at 11:30 A.M. (ET) on October 8th. Hosting the call will be Gerard E. Puorro, the Company's President & Chief Executive Officer and Thomas E. Rohrer, M.D., Clinical Associate Professor, Boston University School of Medicine Boston University School of Medicine (BUSM) is one of the graduate schools of Boston University. It is an American medical school located in the South End neighborhood of Boston, Massachusetts. . During the conference call, members of management will discuss the impact of this FDA approval on the company's business outlook. Dr. Rohrer will be available to answer any clinical questions about Smoothbeam for the treatment of acne. To participate in the conference call, please call: 888-747-3510 or visit the Company's web site at http://www.candelalaser.com. The conference call will begin at 11:30 A.M. (ET) October 8, 2002 If you are unable to participate at the above time, a replay of the call will be available by dialing 888-266-2081 and referring to the pass code 6253322. The replay will run from approximately 2:30 P.M. (ET) on October 8 through 11:59 P.M (ET) on October 11. You may also listen to the conference call live and/or access a replay at candela's web site at http://www.candelalaser.com. For additional information, Call Paul Broyer, Candela Corp Candela Laser Corporation (NASDAQ: CLZR) is an American laser company that develops and sells medical lasers for cosmetic use located in Wayland, Massachusetts. History Candela Laser Corporation was founded in 1970. . 508-358-7637, x435. About Candela: Candela Corporation develops, manufactures, and distributes innovative clinical solutions that enable physicians, surgeons, and personal care practitioners to treat selected cosmetic and medical conditions See carpal tunnel syndrome, computer vision syndrome, dry eyes and deep vein thrombosis. using lasers, aesthetic laser systems, and other advanced technologies. Founded near Boston in 1970, the company markets and services its products in over 60 countries from offices in the United States, Europe, Japan and Asia. Candela established the aesthetic laser market 12 years ago, and currently has an installed base of over 5,000 lasers worldwide. Candela is an Equal Opportunity and Affirmative Action affirmative action, in the United States, programs to overcome the effects of past societal discrimination by allocating jobs and resources to members of specific groups, such as minorities and women. Employer, M/F/H/V M/F/H/V Male/Female/Handicapped/Veteran (employment) . Visit Candela on the Web at www.candelalaser.com. Safe Harbor Safe Harbor 1. A legal provision to reduce or eliminate liability as long as good faith is demonstrated. 2. A form of shark repellent implemented by a target company acquiring a business that is so poorly regulated that the target itself is less attractive. Statement: Except for the historical information contained herein, this news release contains forward-looking statements that constitute Candela's current intentions, hopes, beliefs, expectations or predictions of the future, which are therefore inherently subject to risks and uncertainties. Candela's actual results could differ materially from those anticipated in Candela's forward-looking statements based on various factors, including without limitation: cancellation or deferral of customer orders, total dependence on a small number of strategic distribution relationships, difficulties in the timely development and market acceptance of new products, market developments that vary from the current public expectations concerning the growth of the laser industry, increased competitive pressures, or changes in economic conditions. Further information on factors that could affect Candela's performance is included in Candela's periodic reports filed with the SEC, including but not limited to, Candela's Annual Report on Form 10-K Form 10-K A report required by the SEC from exchange-listed companies that provides for annual disclosure of certain financial information. Form 10-K See 10-K. for the year ended June 29, 2002. Candela cautions readers not to place undue reliance upon any such forward-looking statements, which speak only as of the date made. Candela expressly disclaims any obligations or undertaking to release publicly any updates or revisions to any such statements to reflect any change in Candela's expectations or any change in events, conditions or circumstance on which any such statement is based. |
|
||||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion